Unilever PLC $UL Shares Sold by Pinion Investment Advisors LLC

Pinion Investment Advisors LLC lowered its position in shares of Unilever PLC (NYSE:UL) by 49.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,183 shares of the company’s stock after selling 10,959 shares during the quarter. Pinion Investment Advisors LLC’s holdings in Unilever were worth $684,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Callan Family Office LLC grew its position in shares of Unilever by 199.4% in the second quarter. Callan Family Office LLC now owns 46,228 shares of the company’s stock valued at $2,828,000 after purchasing an additional 30,790 shares in the last quarter. Blair William & Co. IL grew its position in shares of Unilever by 5.5% in the second quarter. Blair William & Co. IL now owns 108,402 shares of the company’s stock valued at $6,631,000 after purchasing an additional 5,652 shares in the last quarter. Game Plan Financial Advisors LLC grew its position in shares of Unilever by 42.0% in the second quarter. Game Plan Financial Advisors LLC now owns 44,223 shares of the company’s stock valued at $2,705,000 after purchasing an additional 13,071 shares in the last quarter. US Bancorp DE grew its position in shares of Unilever by 2.6% in the second quarter. US Bancorp DE now owns 138,412 shares of the company’s stock valued at $8,467,000 after purchasing an additional 3,523 shares in the last quarter. Finally, Optas LLC grew its position in shares of Unilever by 23.0% in the second quarter. Optas LLC now owns 7,407 shares of the company’s stock valued at $453,000 after purchasing an additional 1,387 shares in the last quarter. Institutional investors and hedge funds own 9.67% of the company’s stock.

Wall Street Analysts Forecast Growth

UL has been the subject of several analyst reports. Zacks Research upgraded Unilever from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, September 17th. Jefferies Financial Group reiterated an “underperform” rating on shares of Unilever in a research report on Sunday, August 3rd. Weiss Ratings reiterated a “buy (b)” rating on shares of Unilever in a research report on Wednesday. Finally, CICC Research initiated coverage on Unilever in a research report on Thursday, August 21st. They issued an “outperform” rating for the company. Three analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $73.00.

Unilever Stock Up 0.5%

UL opened at $58.94 on Friday. Unilever PLC has a 52 week low of $54.32 and a 52 week high of $65.66. The business has a fifty day simple moving average of $61.44 and a 200-day simple moving average of $61.59. The firm has a market cap of $144.62 billion, a P/E ratio of 16.89, a P/E/G ratio of 4.26 and a beta of 0.40.

Unilever Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 12th. Stockholders of record on Friday, August 15th were given a dividend of $0.5175 per share. This is an increase from Unilever’s previous quarterly dividend of $0.52. This represents a $2.07 annualized dividend and a dividend yield of 3.5%. The ex-dividend date was Friday, August 15th. Unilever’s dividend payout ratio (DPR) is 59.31%.

Unilever Profile

Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through five segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products consist of the vitamins, minerals, and supplements.